Hematology and Oncology

Home Hematology and Oncology

Cost of Parking at Cancer Center Adds to Patient Financial Burden

Significant positive association seen between daily cost of parking and cost of living in city and for cancer center address transit score

More Frequent Scans Not Linked to Improved Survival After Lung Cancer Surgery

More frequent surveillance not linked to longer recurrence-free, overall survival in pathologic stage I non-small cell lung cancer

2013 to 2017 Saw Significant Drop in U.S. Melanoma Mortality Rates

Significant reduction seen in mortality rate from 2013 to 2017, after the introduction of new treatments in 2011 (most after 2013)

Three-Year Interval Feasible for Stool-Based CRC Screening in Low-Risk People

At three years, test identified more advanced precancerous lesions than expected

Dapagliflozin Reduces Hospitalizations Among Patients With CKD

Reduction seen in rate of admissions due to cardiac disorders, renal and urinary disorders, metabolism and nutrition disorders, neoplasms

Cryoablation More Effective for Some Early-Stage Renal Cell Carcinomas

Increased cancer-specific mortality seen with heat-based thermal ablation versus cryoablation for tumor size 3.1 to 4 cm

Legalization of Medical Marijuana Beneficial for Cancer Patients

Reduction seen in rate of one or more opioid days and in the rate of one or more pain-related hospital events

CVD Risk Increased for Adolescent, Young Adult Cancer Survivors

Odds are disproportionately increased with annual household income <$50,000; are reduced with performance of MVPA

Preexisting Type 2 Diabetes Tied to Later Stage of Cancer Diagnosis

Increased risk seen for nonscreenable cancers

More Biosimilars Marketed in Germany, Switzerland Than U.S.

Monthly treatment costs of biosimilars were higher in the United States than corresponding costs in Germany, Switzerland